Fischer Medical Ventures Ltd (FISCHER) Ratios

0 Followers

Fischer Medical Ventures Ltd Ratios

IN:FISCHER's free cash flow for Q2 2025 was ₹0.24. For the 2025 fiscal year, IN:FISCHER's free cash flow was decreased by ₹ and operating cash flow was ₹0.21. See a summary of the company’s cash flow.

Ratios	TTM	Mar 24	Mar 23	Mar 22
Liquidity Ratios
Current Ratio	3.36	3.59	18.37	0.12
Quick Ratio	3.29	3.50	17.20	0.12
Cash Ratio	0.55	1.02	0.25	0.04
Solvency Ratio	0.39	0.02	0.39	-0.55
Operating Cash Flow Ratio	-1.74	-0.85	-1.92	-0.42
Short-Term Operating Cash Flow Coverage	-14.13	-1.44	0.00	-0.45
Net Current Asset Value	₹ 1.56B	₹ 2.46B	₹ 651.99M	₹ -3.71M
Leverage Ratios
Debt-to-Assets Ratio	0.08	0.19	0.02	2.05
Debt-to-Equity Ratio	0.10	0.25	0.02	-1.70
Debt-to-Capital Ratio	0.09	0.20	0.02	2.44
Long-Term Debt-to-Capital Ratio	0.02	<0.01	0.00	0.00
Financial Leverage Ratio	1.30	1.36	1.06	-0.83
Debt Service Coverage Ratio	3.60	0.05	30.88	-0.56
Interest Coverage Ratio	18.17	7.60	24.82	0.00
Debt to Market Cap	<0.01	<0.01	0.00	0.03
Interest Debt Per Share	0.61	0.59	0.16	2.31
Net Debt to EBITDA	-0.11	-4.44	0.31	-1.98
Profitability Margins
Gross Profit Margin	33.44%	17.26%	21.58%	0.00%
EBIT Margin	19.94%	2.37%	10.38%	0.00%
EBITDA Margin	20.92%	3.85%	11.25%	0.00%
Operating Profit Margin	16.69%	2.76%	8.00%	0.00%
Pretax Profit Margin	19.40%	2.01%	10.06%	0.00%
Net Profit Margin	15.17%	1.09%	8.76%	0.00%
Continuous Operations Profit Margin	15.17%	1.09%	8.76%	0.00%
Net Income Per EBT	78.22%	54.34%	87.05%	117.83%
EBT Per EBIT	116.23%	72.63%	125.85%	0.00%
Return on Assets (ROA)	8.44%	0.26%	2.13%	-122.23%
Return on Equity (ROE)	11.31%	0.36%	2.27%	101.35%
Return on Capital Employed (ROCE)	11.14%	0.86%	2.03%	0.00%
Return on Invested Capital (ROIC)	8.51%	0.39%	1.76%	0.00%
Return on Tangible Assets	8.53%	0.27%	2.19%	-122.23%
Earnings Yield	1.67%	0.01%	0.21%	-1.74%
Efficiency Ratios
Receivables Turnover	1.60	1.45	0.90	0.00
Payables Turnover	4.05	4.43	7.63	0.00
Inventory Turnover	32.98	9.99	3.68	0.00
Fixed Asset Turnover	9.28	2.77	1.68	0.00
Asset Turnover	0.56	0.24	0.24	0.00
Working Capital Turnover Ratio	1.16	0.67	0.63	0.00
Cash Conversion Cycle	148.67	205.38	456.19	0.00
Days of Sales Outstanding	227.78	251.18	404.73	0.00
Days of Inventory Outstanding	11.07	36.52	99.28	0.00
Days of Payables Outstanding	90.18	82.31	47.82	0.00
Operating Cycle	238.85	287.70	504.01	0.00
Cash Flow Ratios
Operating Cash Flow Per Share	-2.10	-0.60	-0.66	-1.03
Free Cash Flow Per Share	-2.29	-0.64	-0.70	-1.03
CapEx Per Share	0.19	0.04	0.04	0.00
Free Cash Flow to Operating Cash Flow	1.09	1.07	1.07	1.00
Dividend Paid and CapEx Coverage Ratio	-11.13	-14.49	-15.16	0.00
Capital Expenditure Coverage Ratio	-11.13	-14.49	-15.16	0.00
Operating Cash Flow Coverage Ratio	-3.69	-1.02	-4.38	-0.45
Operating Cash Flow to Sales Ratio	-0.52	-0.78	-0.35	0.00
Free Cash Flow Yield	-6.29%	-0.82%	-0.91%	-1.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	59.97	9.33K	469.56	-57.37
Price-to-Sales (P/S) Ratio	9.10	101.77	41.13	0.00
Price-to-Book (P/B) Ratio	6.57	33.38	10.64	-58.14
Price-to-Free Cash Flow (P/FCF) Ratio	-15.90	-121.49	-110.12	-75.43
Price-to-Operating Cash Flow Ratio	-17.33	-129.88	-117.38	-75.43
Price-to-Earnings Growth (PEG) Ratio	0.05	-97.87	-2.59	0.00
Price-to-Fair Value	6.57	33.38	10.64	-58.14
Enterprise Value Multiple	43.38	2.64K	365.85	-72.69
Enterprise Value	23.60B	112.46B	8.64B	137.17M
EV to EBITDA	43.38	2.64K	365.85	-72.69
EV to Sales	9.08	101.59	41.17	0.00
EV to Free Cash Flow	-15.87	-121.29	-110.21	-77.54
EV to Operating Cash Flow	-17.29	-129.66	-117.48	-77.54
Tangible Book Value Per Share	5.48	2.29	7.09	-1.33
Shareholders’ Equity Per Share	5.55	2.32	7.29	-1.33
Tax and Other Ratios
Effective Tax Rate	0.22	0.46	0.13	-0.18
Revenue Per Share	4.01	0.76	1.89	0.00
Net Income Per Share	0.61	<0.01	0.17	-1.35
Tax Burden	0.78	0.54	0.87	1.18
Interest Burden	0.97	0.85	0.97	1.05
Research & Development to Revenue	0.00	0.00	0.00	0.00
SG&A to Revenue	0.11	0.05	0.02	0.00
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00
Income Quality	-6.85	-39.02	-3.48	0.90

Currency in INR